| Name | FLT3-IN-17 |
|---|
| Description | FLT3-IN-17 inhibits CYPs and FLT3 mutants activity (IC50s: <0.5 nM for D835Y). FLT3-IN-17 is also a FAK inhibitor, with an IC50 value of 12 nM. FLT3 ligand-2 can be used in the research of cancers[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 12 nM (FAK), <0.5 nM (D835Y)[2]. |
| In Vitro | FLT3-IN-17 (compound 25, 72 h) inhibits cell growth in HCT-116, MDA-MB-231, A375 cells[1]. FLT3-IN-17 (10 μM) inhibits cytochrome P450s (CYPs) with inhibition rates >55%[1]. FLT3-IN-17 inhibits FLT3 mutants activity (IC50s: <0.5 nM for D835Y, 1.6-183 nM for Ba/F3)[1]. Cell Proliferation Assay[1] Cell Line: HCT-116, MDA-MB-231, A375 cells Concentration: 0-1 μM approximately Incubation Time: 72 h Result: Inhibited cell growth with IC50 values of 0.25, 0.46, 0.49 μM respectively. |
| References |
| Molecular Formula | C23H24N6O2S2 |
|---|---|
| Molecular Weight | 480.61 |